Open Access
4 August 2017 Eye tracking in catheter-based cardiovascular interventions: early results
Peter Lanzer M.D., Mohammad Al-Naser, Syed Saqib Bukhari, Andreas R. Dengel, Elizabeth A. Krupinski
Author Affiliations +
Abstract
Visual x-ray image processing (XRIP) represents a fundamental component of catheter-based cardiovascular interventions (CBCVIs). To date, no data are available to define XRIP in this setting. To characterize CBCVI XRIP, we developed a computer-based method allowing continuous temporal–spatial analysis of data recorded by a head-mounted eye-tracking device. Quantitative analysis of gaze duration of an expert operator (EO) revealed that the average time in minutes spent viewing the images on the display screen was 39.5%±13.6% and 41.5%±18.3% of the total recorded time in coronary angiography (CA) and in CA followed by CBCVI, respectively. Qualitative analysis of gaze data of the EO revealed consistent focus on the center point of the screen. Only if suspicious findings were detected did gaze move toward the target. In contrast, a novice operator (NO) observing a subset of cases viewed coronary artery segments separately and sequentially. The developed methodology allows continuous registration and analysis of gaze data for analysis of XRIP strategies of EOs in live-cases scenarios and may assist in the transfer of experts’ reading skills to novices.
CC BY: © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.
Peter Lanzer M.D., Mohammad Al-Naser, Syed Saqib Bukhari, Andreas R. Dengel, and Elizabeth A. Krupinski "Eye tracking in catheter-based cardiovascular interventions: early results," Journal of Medical Imaging 4(3), 035502 (4 August 2017). https://doi.org/10.1117/1.JMI.4.3.035502
Received: 8 February 2017; Accepted: 6 July 2017; Published: 4 August 2017
Lens.org Logo
CITATIONS
Cited by 7 scholarly publications and 1 patent.
Advertisement
Advertisement
Back to Top